Campi, R. Et Al. 2023. Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?. EUROPEAN UROLOGY .

Campi, R., Amparore, D., Marandino, L., Bertolo, R., Erdem, S., Ingels, A., ... Muselaers, S.(2023). Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?. EUROPEAN UROLOGY .

Campi, R. Et Al. "Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?," EUROPEAN UROLOGY , 2023

Campi, R. Et Al. "Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?." EUROPEAN UROLOGY , 2023

Campi, R. Et Al. (2023) . "Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?." EUROPEAN UROLOGY .

@article{article, author={R. Campi Et Al. }, title={Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?}, journal={EUROPEAN UROLOGY}, year=2023}